Latest Ai Technology News

Hiremii Limited reported a 4.4% revenue increase in Q4 FY25 alongside positive operating cash flow, while accelerating commercialisation of its proprietary AI recruitment platform and expanding through a key acquisition.

Hiremii Limited has announced the acquisition of Prince Migration & Education, marking a strategic expansion into Australia's East Coast and diversifying its talent acquisition services with migration expertise.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

Codeifai Limited has confirmed entering a binding agreement to acquire the QuantumAI Secure platform from Credissential Inc, affirming its compliance with ASX continuous disclosure rules amid regulatory scrutiny.

Nanoveu’s subsidiary EMASS has demonstrated a 33% increase in simulated drone flight time using its ultra-low-power ECS-DoT AI chip, marking a significant step toward real-world drone autonomy and efficiency.

SenSen Networks has successfully completed a key contract with Montréal’s Agence de mobilité durable, driving record full-year revenue growth exceeding 20%. The company anticipates strong cash collections into FY26, underscoring its expanding global footprint in AI-driven urban management.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Norwood Systems has successfully delivered a crucial software milestone under a major telecom contract, while also reporting strong customer receipts that bolster its cash position.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.

Straker Ltd reports a solid FY25 performance marked by a strategic shift from legacy translation services to AI-powered language verification, underpinned by robust cash reserves and improved profitability.

Straker Limited reveals Nike will not renew its services contract, impacting a notable portion of its revenue and earnings in the upcoming fiscal year.